Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC
Conditions:   Ebola Virus Disease (Ebola Virus) & Differentials;   Malaria (Plasmodium Falciparum);   Typhoid Fever (Salmonella Typhi/Salmonella Parathyphi);   Dengue Fever (Dengue Virus);   Chikunkunya Fever (Chikunkunya Virus);   Yellow Fever (Yellow Fever Virus) Intervention:   Diagnostic Test: Differential RPA tests Sponsors:   University of Stirling;   Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo;   Institute Pasteur de Dakar, Senegal;   University of Göttingen;   Centre de Recheche du Centre Hospitalier Université Laval Not yet r...
Source: ClinicalTrials.gov - January 21, 2020 Category: Research Source Type: clinical trials

Typhoidal Salmonella human challenge studies: ethical and practical challenges and considerations for low-resource settings
AbstractTyphoidalSalmonella is a major global problem affecting more than 12 million people annually. Controlled human infection models (CHIMs) in high-resource settings have had an important role in accelerating the development of conjugate vaccines againstSalmonella Typhi.The typhoidalSalmonella model has an established safety profile in over 2000 volunteers in high-income settings, and trial protocols, with modification, could be readily transferred to new study sites. To date, a typhoidalSalmonella CHIM has not been conducted in a low-resource setting, although it is being considered.Our article describes the challenge...
Source: Trials - December 18, 2019 Category: Research Source Type: clinical trials

Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine
Condition:   Risk Reduction Interventions:   Biological: Trivalent Invasive Salmonella Disease Vaccine (6.25 µg);   Biological: Trivalent Invasive Salmonella Disease Vaccine (12 µg);   Biological: Trivalent Invasive Salmonella Disease Vaccine (25 µg);   Biological: Trivalent Invasive Salmonella Disease Vaccine (highest, well-tolerate d dose among Cohorts A-C);   Other: Placebo Sponsor:   University of Maryland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2019 Category: Research Source Type: clinical trials